TNFRSF11B and breast carcinoma: We engineered MDA-MB-231-TXSA breast cancer cells to overexpress native full length human OPG and, following their intratibial transplantation, tested the effects of high doses of OPG when produced and secreted locally by breast cancer cells in the bone microenvironment.